Improved Long‐Term Systolic Blood Pressure Control Measured by Time in Target Range Is Associated With Lower Risks of Renal Function Decline and Long‐Term Death Among Patients With Heart Failure

Background Heart failure is associated with renal function decline and increased morbidity and death. We evaluated the association of systolic blood pressure control over time, measured by time in target range (TTR), with renal function decline and death in patients with heart failure. Methods We analyzed a multicenter prospective cohort of patients hospitalized for heart failure across 52 hospitals in China between 2016 and 2018. Systolic blood pressure was measured at 1, 6, and 12 months after discharge. The 12‐month systolic blood pressure TTR was calculated by linear interpolation for a target range of 110 to 130 mm Hg. Outcomes were 1‐year renal function decline (≥20% reduction in estimated glomerular filtration rate from 1 to 12 months plus estimated glomerular filtration rate <60 mL/min per 1.73 m 2 at 12 months) and 5‐year all‐cause death. Results The analysis included 1529 patients for renal function decline and 2195 patients for death. Median follow‐up was 1.0 and 4.2 years, respectively. Renal function decline and death decreased significantly from the lowest to highest TTR tertile ( P trend <0.001 and 0.009, respectively), supported by restricted cubic spline analyses. After multivariable adjustment, each 1‐SD increase in TTR (35%–36%) was associated with lower risks of renal function decline (odds ratio, 0.74 [95% CI, 0.60–0.93]; P =0.008) and all‐cause death (hazard ratio, 0.90 [95% CI, 0.83–0.98]; P =0.01). Results were consistent across subgroups, using 6‐month TTR, and for cardiovascular death. Conclusions Better long‐term systolic blood pressure control, assessed by TTR, was independently associated with lower risks of renal function decline and long‐term death in patients with heart failure. Registration Information clinicaltrials.gov Identifier: NCT02878811

Authors

Institutions

Publication Details

Journal
Journal of the American Heart Association
Published
2026-09-09
DOI
https://doi.org/10.1161/jaha.125.048006
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Improved Long‐Term Systolic Blood Pressure Control Measured by Time in Target Range Is Associated With Lower Risks of Renal Function Decline and Long‐Term Death Among Patients With Heart Failure

Bin Wang, J Liu, Yu Xu, Xinghe Huang et al.
Journal of the American Heart Association
Heart Failure Treatment and Management
article

Improved Long‐Term Systolic Blood Pressure Control Measured by Time in Target Range Is Associated With Lower Risks of Renal Function Decline and Long‐Term Death Among Patients With Heart Failure

Bin Wang, J Liu, Yu Xu, Xinghe Huang, Jingkuo Li, Haibo Zhang, Mian Li, Yan Li, Xin Zheng
article en

Abstract

Background Heart failure is associated with renal function decline and increased morbidity and death. We evaluated the association of systolic blood pressure control over time, measured by time in target range (TTR), with renal function decline and death in patients with heart failure. Methods We analyzed a multicenter prospective cohort of patients hospitalized for heart failure across 52 hospitals in China between 2016 and 2018. Systolic blood pressure was measured at 1, 6, and 12 months after discharge. The 12‐month systolic blood pressure TTR was calculated by linear interpolation for a target range of 110 to 130 mm Hg. Outcomes were 1‐year renal function decline (≥20% reduction in estimated glomerular filtration rate from 1 to 12 months plus estimated glomerular filtration rate <60 mL/min per 1.73 m 2 at 12 months) and 5‐year all‐cause death. Results The analysis included 1529 patients for renal function decline and 2195 patients for death. Median follow‐up was 1.0 and 4.2 years, respectively. Renal function decline and death decreased significantly from the lowest to highest TTR tertile ( P trend <0.001 and 0.009, respectively), supported by restricted cubic spline analyses. After multivariable adjustment, each 1‐SD increase in TTR (35%–36%) was associated with lower risks of renal function decline (odds ratio, 0.74 [95% CI, 0.60–0.93]; P =0.008) and all‐cause death (hazard ratio, 0.90 [95% CI, 0.83–0.98]; P =0.01). Results were consistent across subgroups, using 6‐month TTR, and for cardiovascular death. Conclusions Better long‐term systolic blood pressure control, assessed by TTR, was independently associated with lower risks of renal function decline and long‐term death in patients with heart failure. Registration Information clinicaltrials.gov Identifier: NCT02878811

Journal of the American Heart Association
Shanghai Jiao Tong University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking Union Medical College Hospital (CN)
Good health and well-being
Openalex Percentile: Top 10%
Heart Failure Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.